Inhibrx Biosciences, Inc. (INBX) Insider Trading
Sector: Biotechnology · Market Cap: $1.4B · 0 insider purchases in the last 7 days
No open market insider purchases at Inhibrx Biosciences, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track INBX on your watchlist.
Start for FreeAbout Inhibrx Biosciences, Inc. Insider Trading
2 insiders at Inhibrx Biosciences, Inc. (INBX) have purchased stock in the past 90 days, totaling $3.1M across 7 transactions (30,000 shares).
The most recent purchase was by Director Kayyem Jon Faiz on September 23, 2026 — a $500K buy of 5,000 shares at $100.00, bringing his total holdings to 434,360 shares.
Insiders who purchased: Lappe Mark (CEO, 6 buys totaling $2.6M); Kayyem Jon Faiz (Director, 1 buy totaling $500K).
This insider buying is notable given that INBX had no recorded open market purchases in the nine months before that.
INBX is in the Biotechnology sector within the Biotechnology industry with a market cap of $1.4B.
Track INBX insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.